申请人:ASTRAZENECA AB
公开号:WO2009095712A2
公开(公告)日:2009-08-06
The present invention relates to compounds of Formula (I): and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds provide a treatment for myeloproliferative disorders and cancer.